Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:

Recruiting now

Conditions studied: Parkinson Disease

In brief

Real-World Participants Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States: A Prospective, Phase 4, Multicenter, Observational Study in Parkinson's Disease

Key facts

Study ID

NCT07219927

Run by

Supernus Pharmaceuticals, Inc.

People needed

120

Starts

2025-03-31

Expected to finish

2027-08-01

Last updated by the study team

2025-10-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participant has received a prescription for ONAPGO™ according to the standard of care.
• Participant has opted into receiving support services from the Clinical Nurse Navigator (CNN), a registered nurse specially trained to work with persons with Parkinson's disease, as noted on the Prescription Enrollment Form.
• The HCP/Investigator determines the participant is an appropriate study participant.
• Participant is able and willing to provide informed consent (or informed assent form [IAF], as applicable) and signs the consent form on the Enrollment Day.

You may not qualify if…

• Did not receive a prescription for ONAPGO™.
• Prescribed ONAPGO™, but the HCP/Investigator determines the participant should not participate in this observational study.
• Concomitant use of ONAPGO™ with 5-HT3 antagonists, including antiemetics (e.g., ondansetron, granisetron, dolasetron, palonosetron) or alosetron.
• Known hypersensitivity to apomorphine or to excipients of ONAPGO™, including sulfite (e.g., sodium metabisulfite).

Where it is running

• Parkinson's Disease and Movement Disorders Center - Orange County (South) — Aliso Viejo, California, United States (enrolling)
• Parkinson's Disease and Movement Disorders Center - Orange County (North) — Irvine, California, United States (enrolling)
• Parkinson's Research Centers of America - Palo Alto — Palo Alto, California, United States (enrolling)
• Parkinson's Disease & Movement Disorders Center of Boca Raton — Boca Raton, Florida, United States (enrolling)
• Parkinson's Disease and Movement Disorders Center - Long Island — Commack, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.